Observational study / 2009
Fibromyalgia was not associated with low serum 25-hydroxyvitamin D levels in premenopausal women.
A case-control study assessed serum 25OHD levels in 68 premenopausal women diagnosed with fibromyalgia compared to 82 age-matched controls in Israel. Serum 25OHD was compared between groups using cutoff levels of < 30 ng/ml, < 20 ng/ml, and < 15 ng/ml. No statistically significant differences were observed between the groups regardless of the cutoff used. A logistic regression model predicting women with levels < 20 ng/ml found no significant impact from age, country of birth, or education, indicating no association between fibromyalgia and low 25OHD levels.
Shows an association, not proof of cause and effect.
- Study type
- Case-control study
- Who was studied
- 68 premenopausal women with fibromyalgia and 82 age-matched controls
- What was measured
- Serum 25-hydroxyvitamin D (25OHD) levels
THE PAPER
Serum 25-OH vitamin D levels in patients with fibromyalgia.
Tandeter H, Grynbaum M, Zuili I, Shany S, Shvartzman P. Isr Med Assoc J, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.